You, B., Yanaihara, N., Parma, G., Chabaud, S., Carpio, L. D., Clamp, A. R., Ferron, G., Kroep, J. R., Leary, A., Cibula, D., Fiteni, F., Bruchim, I., Serrier, H., Carroll, S. C., Belmont, A., Peron, J., Chator, C. (2025). SALVOVAR: A pragmatic randomized phase III trial comparing the salvage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic ovarian cancers (GINECO-OV130b; ENGOT-ov78).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps5626